Overview

Thrombolysis Endovascular Treatment of Pulmonary Embolism

Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of endovascular thrombolysis of pulmonary embolism with right ventricular dysfunction with single-dose rtPA
Phase:
Phase 3
Details
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Treatments:
Plasminogen
Tissue Plasminogen Activator